✦ LIBER ✦

Comparing potential benefits of new pneumococcal vaccines with the current polysaccharide vaccine in the elderly

✍ Scribed by Alicia M Fry; Elizabeth R Zell; Anne Schuchat; Jay C Butler; Cynthia G Whitney

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cost-effectiveness of the introduction o

✍ Carlos Castañeda-Orjuela; Nelson Alvis-Guzmán; Ángel José Paternina; Fernando De 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 419 KB

Maternal immunization with pneumococcal

✍ Deborah Lehmann; William S Pomat; Barry Combs; Timothy Dyke; Michael P Alpers 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 94 KB

PIN74 A Cost-Effectiveness Analysis of V

✍ Y. Jiang; A. Gauthier; L. Annemans; M. van der Linden; L. Nicolas-Spony; X. Bres 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

Cost benefits of targeting the Pneumococ

✍ Yeong-Hwang Chen; Guang-Yang Yang; Ching-Hui Loh; Saou-Hsing Liou; Wen-Lin Su; S 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 92 KB

PIN64 Assessing the Cost-Effectiveness (

✍ Y. Jiang; A. Gauthier; S.T. Keeping; S.M. Carroll 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

PIN17 Modelling Budget Impact (BI) of Va

✍ Y. Jiang; A. Gauthier; L. Annemans; M. van der Linden; L. Nicolas-Spony; X. Bres 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB